STOCK TITAN

Fold Holdings sets $25M equity share facility

Fold Holdings establishes a $25 million discretionary equity facility with Roth Principal Investments, capped at 19.99% of pre-deal shares outstanding.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Fold Holdings, Inc. (FLD) entered into a Common Stock Purchase Agreement and related Registration Rights Agreement with Roth Principal Investments, LLC, creating a committed equity facility of up to $25,000,000 in newly issued common shares. The company may, at its sole discretion over up to 36 months after commencement, direct Roth to buy shares through various VWAP-based purchase types (Market Open, Intraday, Pre-Market and Post-Market Purchases) at discounts of 3.0% or 5.0% to VWAP, subject to pricing, volume and other conditions.

Issuances are limited by Nasdaq’s 19.99% Exchange Cap of 10,942,804 shares unless shareholder approval or specified pricing conditions are met, and by a 4.99% beneficial ownership cap for Roth. Initial issuances rely on a private placement exemption, with a resale registration statement to be filed. Fold plans to use any net proceeds for product development, working capital and general corporate purposes and will pay Roth a commitment fee of up to $500,000 through 10% cash withholdings on purchases, and $50,000 to Compass Point as qualified independent underwriter.

Positive

  • Creates access to up to $25,000,000 in flexible equity financing over 36 months, with timing and usage fully at the company’s discretion.
  • Sets VWAP-based pricing with fixed 3.0% and 5.0% discounts, providing a transparent framework for potential share sales to Roth Principal Investments.

Negative

  • Facility allows issuance of up to 10,942,804 shares, equal to 19.99% of pre-agreement outstanding stock, creating a clearly disclosed potential dilution for existing shareholders.

Filing Explained

The agreement creates up to $25 million of optional equity issuance, but no purchase obligation or completed issuance is reported before registration becomes effective.

As a Form 8-K material-event report, the filing records that on September 4, 2026 Fold signed the purchase and registration-rights agreements. The financing is not yet at Commencement: the company must first satisfy conditions including effectiveness of the resale registration statement, and it has no obligation to sell shares.

If exercised, the arrangement gives Fold capacity to issue new common stock for up to $25,000,000. New shares increase the total share count and can reduce existing holders’ percentage ownership; that effect remains conditional because Fold controls the timing and amount of sales.

During the agreement’s term, Fold is also restricted, subject to exceptions, from entering specified variable-rate transactions such as another equity line or at-the-market offering. The agreement may terminate after 36 months from Commencement, after the maximum purchase amount is reached, or on other stated events; either party may also terminate on 10 trading days’ notice under the specified conditions.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Equity facility size $25,000,000 Maximum aggregate gross purchase price of common stock Roth Principal Investments may buy
Exchange Cap shares 10,942,804 shares Equals 19.99% of common shares outstanding immediately before the Purchase Agreement
Exchange Cap percentage 19.99% Nasdaq cap on issuances to Roth without shareholder approval or pricing relief
Beneficial ownership limit 4.99% Maximum beneficial ownership in Fold common stock permitted for Roth and affiliates
VWAP discount (Market Open/Intraday) 3.0% Fixed discount to VWAP used to set per-share purchase price
VWAP discount (Pre-/Post-Market) 5.0% Fixed discount to VWAP for Pre-Market and Post-Market Purchases
Commitment Fee $500,000 Aggregate fee to Roth, funded via 10% withholding from each purchase
Qualified independent underwriter fee $50,000 Fee payable to Compass Point for acting as qualified independent underwriter
volume weighted average price financial
"determined by reference to the volume weighted average price of the Common Stock"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.
Exchange Cap financial
"may not issue to Roth Principal Investments under the Purchase Agreement more than 10,942,804 shares"
Beneficial Ownership Limitation financial
"would result in Roth Principal Investments beneficially owning more than 4.99% of the outstanding shares"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Variable Rate Transactions financial
"prohibition on entering into specified "Variable Rate Transactions" during the term of the Purchase Agreement"
Registration Statement regulatory
"a registration statement registering under the Securities Act for the resale by Roth Principal Investments"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
qualified independent underwriter financial
"engaged Compass Point ... to be the qualified independent underwriter in connection with the offering"
A qualified independent underwriter is a financial firm that is both eligible under regulatory rules and free of close ties to the issuing company, so it can buy, price and sell a new batch of securities without conflicts of interest. Investors treat its involvement like a neutral referee: its role helps set a fair market price, adds credibility to the deal and reduces the risk that shares are being pushed on biased or poorly vetted terms.

FAQ

What financing agreement did FLD enter with Roth Principal Investments?

Fold Holdings entered a Common Stock Purchase Agreement giving it the right, but not the obligation, to sell up to $25,000,000 of newly issued common stock to Roth Principal Investments over up to 36 months, subject to conditions and Nasdaq-related caps.

How many FLD shares can be issued under the equity facility before shareholder approval is required?

Fold Holdings may issue up to 10,942,804 shares of common stock to Roth Principal Investments, equal to 19.99% of shares outstanding immediately before the agreement, unless it obtains stockholder approval or specified pricing conditions are met.

How is the purchase price of FLD shares determined for Roth under the agreement?

Purchase prices are based on the shares’ volume weighted average price (VWAP) over defined trading periods, less a fixed 3.0% discount for Market Open and Intraday Purchases and a fixed 5.0% discount for Pre-Market and Post-Market Purchases.

What ownership limits apply to Roth Principal Investments in FLD?

Fold Holdings may not issue or sell shares to Roth Principal Investments if doing so would cause Roth and its affiliates to beneficially own more than 4.99% of the outstanding common stock, calculated under Section 13(d) and Rule 13d-3.

How will FLD use proceeds from sales of stock to Roth Principal Investments?

Fold Holdings states that any net proceeds from sales of common stock to Roth Principal Investments, if and when made, are currently planned to be used for product development, working capital, and general corporate purposes.

What fees are associated with FLD’s agreement with Roth Principal Investments and Compass Point?

Fold Holdings will pay Roth Principal Investments a $500,000 commitment fee via 10% cash withholdings from each purchase, and will pay Compass Point $50,000 for acting as qualified independent underwriter on the resale registration offering.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false00018891230001889123fld:CommonStockParValue0.0001PerShareMember2026-09-042026-09-0400018891232026-09-042026-09-040001889123fld:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember2026-09-042026-09-04

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 4, 2026

Fold Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-41168

86-2170416

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

2942 North 24th Street, Suite 115, #42035

Phoenix, Arizona

 

 

85016

(Address of principal executive offices)

(Zip Code)

 

(866) 365-3277

Registrant’s telephone number, including area code

 

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which
Registered

Common stock, par value $0.0001 per share

FLD

Nasdaq Capital Market

Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share

FLDDW

Nasdaq Capital Market

 

 


 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

 

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

 

On September 4, 2026, Fold Holdings, Inc. (the "Company") entered into a Common Stock Purchase Agreement (the "Purchase Agreement") and a related Registration Rights Agreement (the "Registration Rights Agreement") with Roth Principal Investments, LLC ("Roth Principal Investments"). Upon the terms and subject to the satisfaction of the conditions set forth in the Purchase Agreement, the Company will have the right, in its sole discretion, to sell to Roth Principal Investments up to $25,000,000 of newly issued shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), subject to certain conditions and limitations contained in the Purchase Agreement, from time to time during the term of the Purchase Agreement. Sales of Common Stock pursuant to the Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the Company is under no obligation to sell any securities to Roth Principal Investments under the Purchase Agreement.

 

Upon the initial satisfaction of each of the conditions to Roth Principal Investments' purchase obligation set forth in the Purchase Agreement (the initial satisfaction of such conditions, the "Commencement," and the date on which the Commencement occurs, the "Commencement Date"), including that a registration statement registering under the Securities Act of 1933, as amended (the "Securities Act") for the resale by Roth Principal Investments of shares of Common Stock issued to it by the Company under the Purchase Agreement, which the Company agreed to file with the Securities and Exchange Commission (the "SEC") pursuant to the Registration Rights Agreement (the "Registration Statement"), is declared effective by the SEC, the Company will have the right, but not the obligation, from time to time in its sole discretion for a period of up to 36 months beginning on the Commencement Date, to direct Roth Principal Investments to purchase up to a specified maximum amount of shares of Common Stock, in one or more Market Open Purchases, Intraday Purchases, Pre-Market Purchases and/or Post-Market Purchases (each as defined below, and together, the "Purchases"), by timely delivering written notice to Roth Principal Investments for each such Purchase in accordance with the Purchase Agreement on any trading day selected by the Company as the purchase date therefor (the "Purchase Date"), so long as (i) the closing sale price of the Common Stock on the trading day immediately prior to such Purchase Date (or, in the case of a Post-Market Purchase, on such Purchase Date) is not less than $0.10 (the "Threshold Price") and (ii) all shares of Common Stock subject to all prior Purchases effected by the Company under the Purchase Agreement have been received by Roth Principal Investments at such time and in the manner set forth in the Purchase Agreement.

 

The purchase price of the shares of Common Stock that the Company elects to sell to Roth Principal Investments in a Purchase pursuant to a timely delivered written notice in accordance with the Purchase Agreement after 7:30 a.m., New York City time, and prior to 9:00 a.m., New York City time, on the Purchase Date (a "Market Open Purchase") will be determined by reference to the volume weighted average price of the Common Stock ("VWAP") during the period (the "Market Open Purchase Period") beginning at the official open of the regular trading session on The Nasdaq Capital Market on the applicable Purchase Date and ending at the earliest to occur of (i) such time of official close of the regular trading session, (ii) such time during such regular trading hour period that the trading volume threshold calculated in accordance with the Purchase Agreement is reached, and (iii) if the Company further specifies in the applicable purchase notice for such Market Open Purchase that a "limit order discontinue election" shall apply to such Market Open Purchase, such time the trading price of the Common Stock on The Nasdaq Capital Market during such Market Open Purchase Period falls below the applicable minimum price threshold determined in accordance with the Purchase Agreement, less a fixed 3.0% discount to the VWAP for such Market Open Purchase Period.

 

In addition to the Market Open Purchases described above, after the Commencement, the Company will also have the right, but not the obligation (subject to the continued satisfaction of the purchase conditions contained in the Purchase Agreement), to direct Roth Principal Investments to purchase, on any trading day that would qualify as a Purchase Date on which the Company may elect to effect a Market Open Purchase, whether or not a Market Open Purchase is effected by the Company on such trading day, a specified number of shares of Common Stock, not to exceed certain limitations set forth in the Purchase Agreement that are similar to those applicable to Market Open Purchases (each, an "Intraday Purchase"), by timely delivering an irrevocable written notice of such Intraday Purchase to Roth Principal Investments after 10:00 a.m., New York City time (and after the Market Open Purchase Period for any earlier Market Open Purchase and the Intraday Purchase Period for the most recent prior Intraday Purchase effected on the same Purchase Date, if applicable, have ended), and prior to 2:00 p.m., New York City time, on such Purchase Date (each, an "Intraday Purchase Notice").

 


 

 

The per share purchase price for the shares of Common Stock that the Company elects to sell to Roth Principal Investments in an Intraday Purchase pursuant to the Purchase Agreement, if any, will be calculated in the same manner as in the case of a Market Open Purchase (including the same fixed 3.0% discount to the applicable VWAP used to calculate the per share purchase price for a Market Open Purchase, as described above), provided that the VWAP for each Intraday Purchase effected on a Purchase Date will be calculated over different purchase valuation periods during the regular trading session on The Nasdaq Capital Market on such Purchase Date than the Market Open Purchase Period applicable to a Market Open Purchase effected on such Purchase Date (if any), each of which will commence and end at different times on such Purchase Date and will not overlap with any other purchase valuation period on such Purchase Date (each, an "Intraday Purchase Period").

 

In addition to the Market Open Purchases and Intraday Purchases described above, after the Commencement, the Company will also have the right, but not the obligation (subject to the continued satisfaction of the purchase conditions contained in the Purchase Agreement), to direct Roth Principal Investments to purchase, on any trading day that would qualify as a Purchase Date on which the Company may elect to effect a Market Open Purchase, whether or not a Market Open Purchase is effected by the Company on such trading day, a specified number of shares of Common Stock, not to exceed certain limitations set forth in the Purchase Agreement (each, a "Pre-Market Purchase"), by timely delivering an irrevocable written notice of such Pre-Market Purchase to Roth Principal Investments after 7:00 a.m., New York City time, and prior to 8:30 a.m., New York City time, on such Purchase Date (each, a "Pre-Market Purchase Notice").

 

The per share purchase price for the shares of Common Stock that the Company elects to sell to Roth Principal Investments in a Pre-Market Purchase pursuant to the Purchase Agreement, if any, will be calculated by reference to the VWAP of the Common Stock during the applicable Pre-Market Purchase Period, less a fixed 5.0% discount to such VWAP, provided that the VWAP for each Pre-Market Purchase effected on a Purchase Date will be calculated over different purchase valuation periods on The Nasdaq Capital Market on such Purchase Date than the Market Open Purchase Period applicable to a Market Open Purchase effected on such Purchase Date (if any), each of which will commence and end at different times on such Purchase Date and will not overlap with any other purchase valuation period on such Purchase Date (each, a "Pre-Market Purchase Period").

 

In addition to the Market Open Purchases, Intraday Purchases and Pre-Market Purchases described above, after the Commencement, the Company will also have the right, but not the obligation (subject to the continued satisfaction of the purchase conditions contained in the Purchase Agreement), to direct Roth Principal Investments to purchase, on any trading day that would qualify as a Purchase Date on which the Company may elect to effect a Market Open Purchase, whether or not a Market Open Purchase is effected by the Company on such trading day, a specified number of shares of Common Stock, not to exceed certain limitations set forth in the Purchase Agreement (each, a "Post-Market Purchase"), by timely delivering an irrevocable written notice of such Post-Market Purchase to Roth Principal Investments after 4:05 p.m., New York City time, and prior to 5:00 p.m., New York City time, on such Purchase Date (each, a "Post-Market Purchase Notice").

 

The per share purchase price for the shares of Common Stock that the Company elects to sell to Roth Principal Investments in a Post-Market Purchase pursuant to the Purchase Agreement, if any, will be calculated by reference to the VWAP of the Common Stock during the applicable Post-Market Purchase Period, less a fixed 5.0% discount to such VWAP, provided that the VWAP for each Post-Market Purchase effected on a Purchase Date will be calculated over different purchase valuation periods on The Nasdaq Capital Market on such Purchase Date than the Market Open Purchase Period applicable to a Market Open Purchase effected on such Purchase Date (if any), each of which will commence and end at different times on such Purchase Date and will not overlap with any other purchase valuation period on such Purchase Date (each, a "Post-Market Purchase Period," and together with the Market Open Purchase Period, Intraday Purchase Period and Pre-Market Purchase Period, the "Purchase Period").

 

The Company will control the timing and amount of any sales of Common Stock to Roth Principal Investments that it may elect, in its sole discretion, to effect from time to time from and after the Commencement Date and during the term of the Purchase Agreement. Actual sales of shares of Common Stock to Roth Principal Investments under the Purchase Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among other things, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.

 


 

 

Under the applicable Nasdaq rules, the Company may not issue to Roth Principal Investments under the Purchase Agreement more than 10,942,804 shares of Common Stock, which number of shares is equal to 19.99% of the shares of Common Stock issued and outstanding immediately prior to the execution of the Purchase Agreement (the "Exchange Cap"), unless (i) the Company obtains stockholder approval to issue shares of Common Stock in excess of the Exchange Cap in accordance with applicable Nasdaq rules, or (ii) the average price per share paid by Roth Principal Investments for all of the shares of Common Stock that the Company directs Roth Principal Investments to purchase from the Company pursuant to the Purchase Agreement, if any, equals or exceeds the sum of $0.0457 and the lower of the (x) official closing price of the Common Stock on Nasdaq immediately preceding the execution of the Purchase Agreement and (y) the average official closing price of the Common Stock on Nasdaq for the five consecutive trading days immediately preceding the execution of the Purchase Agreement, in each case as adjusted in accordance with applicable Nasdaq rules.

 

In addition, the Company may not issue or sell any shares of Common Stock to Roth Principal Investments under the Purchase Agreement which, when aggregated with all other shares of Common Stock then beneficially owned by Roth Principal Investments and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 13d-3 thereunder), would result in Roth Principal Investments beneficially owning more than 4.99% of the outstanding shares of Common Stock.

 

The net proceeds from sales of Common Stock by the Company to Roth Principal Investments under the Purchase Agreement, if any, will depend on the frequency and prices at which the Company sells shares of Common Stock to Roth Principal Investments under the Purchase Agreement. To the extent the Company elects to sell shares of Common Stock to Roth Principal Investments under the Purchase Agreement from and after the Commencement Date, the Company currently plans to use any net proceeds therefrom for product development, working capital and general corporate purposes.

 

There are no rights of first refusal, participation rights, penalties or liquidated damages in the Purchase Agreement or Registration Rights Agreement, other than a prohibition (with certain limited exceptions) on entering into specified "Variable Rate Transactions" (as such term is defined in the Purchase Agreement) during the term of the Purchase Agreement. Such transactions include, among others, the Company effecting or entering into an agreement to effect an "equity line of credit" or "at the market offering" or other substantially similar continuous offering with a third party, in which the Company may offer, issue or sell Common Stock or any securities exercisable, exchangeable or convertible into Common Stock at a future determined price, subject to certain exceptions.

 

The initial issuances of Common Stock to Roth Principal Investments under the Purchase Agreement will be made in reliance on the exemption from the registration requirements of the Securities Act provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. The Company has agreed to file the Registration Statement to register the resale by Roth Principal Investments of the shares of Common Stock issued to it under the Purchase Agreement, upon the terms and subject to the conditions set forth in the Registration Rights Agreement.


The Purchase Agreement and the Registration Rights Agreement contain customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for the purposes of such agreements, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.


The Purchase Agreement will automatically terminate on the earliest to occur of (i) the first day of the month following the 36-month anniversary of the Commencement Date, (ii) the date on which Roth Principal Investments shall have purchased from the Company under the Purchase Agreement shares of Common Stock for an aggregate gross purchase price of $25,000,000, (iii) the date on which the Common Stock shall have failed to be listed or quoted on Nasdaq or another U.S. national securities exchange identified as an "eligible market" in the Purchase Agreement for a period of one trading day, (iv) the 30th trading day after the date on which a voluntary or involuntary bankruptcy proceeding involving the Company has been commenced that is not discharged or dismissed prior to such 30th trading day, and (v) the date on which a bankruptcy custodian is appointed for all or substantially all of the Company's property or the Company makes a general assignment for the benefit of its creditors.

 

 


 

The Company has the right to terminate the Purchase Agreement, at no cost or penalty to the Company, upon 10 trading days' prior written notice to Roth Principal Investments, provided that the Company has paid all amounts of the Commitment Fee (as further described below) and legal fee reimbursements then required to be paid to Roth Principal Investments under the Purchase Agreement. Roth Principal Investments has the right to terminate the Purchase Agreement upon 10 trading days' prior written notice to the Company upon the occurrence of certain events, including a material adverse effect with respect to the Company, a fundamental transaction involving the Company, certain failures relating to the effectiveness or availability of the Registration Statement, a suspension of trading in the Common Stock for five consecutive trading days, or an uncured material breach or default by the Company under the Purchase Agreement. The Company and Roth Principal Investments may also agree to terminate the Purchase Agreement by mutual written consent, provided that no termination of the Purchase Agreement will be effective during the pendency of any Purchase that has not then fully settled in accordance with the Purchase Agreement. Neither the Company nor Roth Principal Investments may assign or transfer any of their respective rights or obligations under the Purchase Agreement or the Registration Rights Agreement.

 

In consideration for Roth Principal Investments' commitment to purchase shares of Common Stock at the Company's direction upon the terms and subject to the conditions set forth in the Purchase Agreement, the Company has agreed to pay to Roth Principal Investments a commitment fee (the "Commitment Fee") of up to $500,000 in the aggregate, which the Company and Roth Principal Investments have agreed will be paid and satisfied by Roth Principal Investments' withholding of an amount in cash equal to 10% of the purchase price otherwise payable by Roth Principal Investments to the Company in respect of each Purchase effected under the Purchase Agreement, until Roth Principal Investments shall have received an aggregate of $500,000 from such withholdings.

 

The Company has engaged Compass Point Research & Trading, LLC, a registered broker-dealer and FINRA member (“Compass Point”), to be the qualified independent underwriter in connection with the offering to be registered under the Registration Statement and, in such capacity, participate in the preparation of the Registration Statement and exercise the usual standards of “due diligence” with respect thereto, in order for such offering to be in full compliance with the applicable rules and regulations of the Financial Industry Regulatory Authority, Inc. (“FINRA”), including FINRA Rule 5121. The Company has agreed to pay Compass Point $50,000 as consideration for its services in connection with acting as the qualified independent underwriter in the offering to be registered under the Registration Statement. Compass Point will receive no other compensation for acting as the qualified independent underwriter in connection with such offering.

 

The foregoing descriptions of the Purchase Agreement and the Registration Rights Agreement are qualified in their entirety by reference to the full text of such agreements, copies of which are attached hereto as Exhibit 10.1 and Exhibit 10.2, respectively, and each of which is incorporated herein in its entirety by reference.

 

ITEM 3.02. UNREGISTERED SALES OF EQUITY SECURITIES.

 

The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K relating to the issuance of shares of Common Stock to Roth Principal Investments under the Purchase Agreement is incorporated by reference into this Item 3.02. Any shares of Common Stock issued to Roth Principal Investments under the Purchase Agreement prior to the effectiveness of the Registration Statement will be issued in reliance on the exemption from the registration requirements of the Securities Act provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder, based on, among other things, the representations and warranties of Roth Principal Investments contained in the Purchase Agreement, including that Roth Principal Investments is an "accredited investor" as defined in Rule 501(a) of Regulation D.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains “forward-looking statements” relating to the Company’s business, including statements related to the satisfaction of the conditions to Roth Principal Investments’ purchase obligations and the intended use of any proceeds to the Company from the sale of shares of Common Stock pursuant to the Purchase Agreement, that are often identified using “believes”, “expects”, or similar expressions. Forward-looking statements involve several estimates, assumptions, risks, and other uncertainties that may cause actual results to be materially different from those anticipated, believed, estimated, expected, etc. Accordingly, forward-looking statements are not guarantees of future results. Actual results could differ from those projected due to numerous factors

 


 

and uncertainties. Although the Company believes that the expectations, opinions, projections, and comments reflected in these forward-looking statements are reasonable, the Company can give no assurance that such statements will prove to be correct, and that the Company’s actual results of ‎operations, financial condition and performance will not differ materially from the ‎results of operations, financial condition and performance reflected or implied by these forward-‎looking statements. Undue reliance should not be placed on the forward-looking statements and investors should refer to the risk factors outlined in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and the Company’s subsequent filings with the SEC. These forward-looking statements are made as of the date hereof, and the Company assumes no obligation to update these statements or the reasons why actual results could differ from those projected, except as required by law.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

Exhibit No.

Description

10.1*^

Common Stock Purchase Agreement, dated as of September 4, 2026, by and between the Company and Roth Principal Investments, LLC

10.2*^

 

Registration Rights Agreement, dated as of September 4, 2026, by and between the Company and Roth Principal Investments, LLC

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of such schedules, or any section thereof, to the SEC upon request.

 

^ Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The registrant agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.

 

 


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

FOLD HOLDINGS, INC.

By:

 /s/ Will Reeves

Name:

Will Reeves

Title:

Chief Executive Officer

Dated: September 8, 2026

 

 

 


Filing Exhibits & Attachments

3 documents

Keep reading